Testing effectiveness (Phase 2)UnknownNCT05345873
What this trial is testing
Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years
Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300